Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2
Update: 2023-02-22
Description
Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.
In this video, Dr. Tara discusses:
- (0:34 ) Impacts of Ferring's FDA approval on Microba
- (5:30 ) Drivers behind Microba's increase in revenue
- (7:12 ) What 2023 looks like for Monash IVF
- (8:39 ) Monash IVF's rating
- (11:45 ) Monash IVF's impact from legal action
Note: This interview was filmed on 7 February 2023.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
